Imperial College London


Faculty of MedicineDepartment of Surgery & Cancer

Research Associate



+44 (0)20 7594 2823silvia.ottaviani07




ICTEM buildingHammersmith Campus






Peng L, Xiao K, Ottaviani S, et al., 2020, A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib., Expert Opin Drug Saf

Stebbing J, Krishnan V, de Bono S, et al., 2020, Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients., Embo Molecular Medicine, ISSN:1757-4676

Richardson PJ, Ottaviani S, Prelle A, et al., 2020, CNS penetration of potential anti-COVID-19 drugs., Journal of Neurology, Vol:267, ISSN:0340-5354, Pages:1880-1882

Ottaviani S, Stebbing J, 2020, What is the best drug to treat COVID-19? The need for randomized controlled trials, Medicine, ISSN:1357-3039

Ottaviani S, Stebbing J, Frampton AE, et al., 2019, Author Correction: TGF-beta induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression, Nature Communications, Vol:10, ISSN:2041-1723

More Publications